Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan.

Saved in:
Bibliographic Details
Title: Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan.
Authors: Wang FD; Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Institute of Public Health, National Yang-Ming Chiao-Tung University, Taipei, Taiwan., Chang YH; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan., Chuang HC; Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan., Ou TY; Division of Infectious Diseases, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan., Lee MH; Division of Infectious Diseases, Department of Internal Medicine, Shuang Ho Hospital, New Taipei City, Taipei Medical University, Taipei, Taiwan., Nguyen PA; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei City, Taiwan; Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan; Research Center of Health Care Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan., Phan TP; International PhD Program in Biotech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan., Burton W; International PhD Program in Biotech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan., Nguyen TKH; Ph.D. Program in School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan., Hsu MH; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei City, Taiwan; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan; Office of Data Science, Taipei Medical University, Taipei, Taiwan., Lin SM; Research Center of Health Care Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan., Yang C; Research Center of Health Care Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan., Hsu JC; Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan; Clinical Big Data Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan; Research Center of Health Care Industry Data Science, College of Management, Taipei Medical University, Taipei, Taiwan; International PhD Program in Biotech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan. Electronic address: jasonhsu@tmu.edu.tw.
Source: Journal of infection and public health [J Infect Public Health] 2025 Jun; Vol. 18 (6), pp. 102760. Date of Electronic Publication: 2025 Mar 18.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101487384 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-035X (Electronic) Linking ISSN: 18760341 NLM ISO Abbreviation: J Infect Public Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1876-035X
DOI:10.1016/j.jiph.2025.102760